(Q33689293)

28 July 2017

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

6

Mark F Munsell

1 reference

28 July 2017

4

Shannon N Westin

1 reference

28 July 2017

12

Karen H Lu

1 reference

28 July 2017

2

Brian M Slomovitz

1 reference

28 July 2017

Larissa A Meyer

1

1 reference

28 July 2017

Bojana Djordjevic

3

1 reference

28 July 2017

David A Iglesias

5

1 reference

28 July 2017

Yunyun Jiang

7

1 reference

28 July 2017

Rosemarie Schmandt

8

1 reference

28 July 2017

Russell R Broaddus

9

1 reference

28 July 2017

Robert L Coleman

10

1 reference

28 July 2017

John M Galbincea

11

1 reference

28 July 2017

1 May 2014

1 reference

International Journal of Gynecological Cancer

28 July 2017

1 reference

28 July 2017

24

1 reference

28 July 2017

713-717

1 reference

28 July 2017

4

1 reference

Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

21 June 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies: current status and future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Chemotherapy in endometrial cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

High frequency of mutations of the PIK3CA gene in human cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039301

K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome

21 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24651628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer: the road to Amiens

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24651628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24651628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/IGC.0000000000000118

1 reference

28 July 2017

1 reference

28 July 2017

1 reference